We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » EU States Suspend Marketing Nods For Generics Vetted by GVK
EU States Suspend Marketing Nods For Generics Vetted by GVK
Several EU member states suspended marketing authorization for therapies that underwent bioequivalence testing at contract research organization GVK Biosciences’ facility in Hyderabad, India, citing serious concerns about deviations from good clinical practice.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor